Israeli biomed company PROLOR Biotech Inc. has been acquired by American company Opko Health Inc. Opko, which is based in Miami, will pay $480 million for the Israeli company, which has an estimated market worth of $370 million. PROLOR’s lead product is a longer-lasting human growth hormone.
Related posts
Israel Invests Millions To Help AI Comprehend Hebrew, Arabic
September 21, 2023
Cybersecurity Startup Cato Raises $238M With $3B Valuation
September 21, 2023
Israel, UK Ink Deal For Greater Innovation Collaboration
September 21, 2023
ALS Drug Receives Patent In Israel, Europe, Japan
September 20, 2023
Facebook comments